IQ Capital

We are a dedicated deep tech venture capital firm.

United Kingdomseed
Firm site

Firm

Firm

We are a dedicated deep tech venture capital firm. Our culture is built on the conviction that technology is the primary engine of societal and economic progress. We prioritise teams creating breakthrough technologies across the largest global markets. IQ Capital is a dedicated European deep tech venture capital firm, built on the conviction that frontier technology will underpin the next generation of globally significant companies. We lead rounds at pre-Seed to Series A and with our growth opportunity funds can follow-on with up to $40m. Over six fund cycles, our team has supported founders through to acquisition by some of the world's largest technology companies, including Apple, Meta, Google, Siemens, Qualcomm, and Oracle. “Working with IQ Capital has been an incredible experience. Their deep understanding of the challenges and opportunities within deep tech, combined with their strategic guidance and unwavering support, has been instrumental in helping us scale.” “Partnering with IQ Capital was a game-changer for our company. They have gone far beyond providing capital – their strategic insights and hands-on support have been instrumental in making the leap from research to building a scalable company.” “IQ Capital has been instrumental in our journey. It is rare for a VC fund to provide so much value with the product-market-fit iterations – their deep technical understanding is unparalleled and they helped us take our product marketing to the next level.” Team Deep tec

Geography

Geography

United Kingdom

Stage

Stage

seed

Themes

Themes

Deep tech

Portfolio

Portfolio

Gravis Robotics, Trogenix, Rivan, DreamFold, Mytos, QuantumDiamonds

Company

Company

LinkedIn Gravis Robotics' mission is to transform heavy construction equipment into intelligent, autonomous machines, addressing industry challenges of stagnant productivity and labour shortages.

Company

Company

LinkedIn Trogenix’s mission is to develop effective, safe genetic medicines that are curative against multiple types of cancer and longevity-related disorders. Trogenix is building a next-generation gene therapy platform to address the key challenges of safety and specificity in oncology. Using proprietary synthetic super enhancers (SSEs), Trogenix precisely targets therapeutic payloads to diseased cells, minimising off-target effects and maximising efficacy. A spinout from the University of Edinburgh in 2023, Trogenix aims to redefine targeted cancer treatments, with an initial application in brain cancer (glioblastoma).

Company

Company

LinkedIn Rivan is building the infrastructure to produce synthetic fuels domestically in Europe, using renewable energy and carbon captured from the air. Rivan vertically integrates solar generation, electrolysis, direct air capture and methanation to produce synthetic methane, a drop-in renewable substitute for natural gas. Its e-methane moves through existing gas infrastructure, creating a practical pathway to decarbonise heavy industry, transport and grid injection while strengthening Europe’s energy security. Rivan was founded in 2024 by serial entrepreneur Harvey Hodd, and has assembled an elite team of 30+ electrical, chemical, and mechanical engineers working from its HQ in London.